Radiation Therapy for Lymphoma
Trial Summary
What is the purpose of this trial?
This study focuses on using shortened courses of radiation for participants with relapsed/refractory Hodgkin/Non-Hodgkin lymphoma. Treatment radiation over 5-6 weeks is often standard of care for many people with lymphoma, but doctors leading this study aim to find out if using radiation for a shorter period of time can be safe for treating lymphoma and if so, what is the safest shortened dose of radiation for participants.
Research Team
Yasmin Hasan, MD
Principal Investigator
University of Chicago - Comprehensive Cancer Center
Eligibility Criteria
Adults over 18 with relapsed/refractory Hodgkin/non-Hodgkin lymphoma, who've tried standard treatments without success. They must have measurable disease and be in relatively good health (ECOG โค 2). Women of childbearing age need a negative pregnancy test and agree to contraception; men must also follow contraceptive guidelines.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Radiation Treatment
Participants receive high-energy radiation to a focused area of the body using a linear accelerator. The treatment duration varies from 3 treatments in less than 1 week to 14 treatments over 3 weeks, depending on the dose group.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments for adverse events and overall survival.
Treatment Details
Interventions
- Radiation
Radiation is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- Cancer treatment
- HPV-positive throat cancer
- Various types of tumors
- Cancer treatment
- HPV-positive throat cancer
- Various types of tumors
- Cancer treatment
- HPV-positive throat cancer
- Various types of tumors
- Cancer treatment
- HPV-positive throat cancer
- Various types of tumors
- Cancer treatment
- HPV-positive throat cancer
- Various types of tumors
- Cancer treatment
- HPV-positive throat cancer
- Various types of tumors
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Chicago
Lead Sponsor